Key result
Intensive BP lowering benefits only specific hypertensive subgroups rather than the general population.
Why the study?
Debate persists regarding optimal blood pressure goals to reduce morbidity and mortality, and current trial data on intensive lowering are not easily applicable to the general hypertensive population.
Does intensive blood pressure lowering reduce morbidity and mortality in patients with hypertension?
Does intensive blood pressure lowering reduce morbidity and mortality in patients with hypertension?
This review highlights that intensive blood pressure lowering should be individualized based on reliable measurements and is not universally applicable to the general hypertensive population.
Intensive BP lowering warrants subgroup-specific caution; leaves open optimal targets for general hypertension pending more applicable trials.
According to the last Hypertension guideline recommendations, it may be concluded that intensive BP lowering is only advisable in a subgroup of patients where there is a clear net benefit of targeting to lower BP goals. However, taking into account the relevance of correct BP measurement, estimates of the benefits versus the harm should be based on reliable office BP measurements and home BP measurements.There is still debate about which BP goals are optimal in reducing morbidity and mortality in uncomplicated hypertensives and in those with associated comorbidities. In recent years, trials and meta-analyses have assessed intensive BP lowering, with some success. However, a careful examination of the results shows that current data are not easily applicable to the general hypertensive population.This article reviews the evidence on and controversies about intensive BP lowering in general and in specific clinical situations, and the importance of obtaining reliable BP readings in patients with hypertension and comorbidities.
No takes yet. Share an insight, caveat, or question.
Camafort et al. (2020) conducted a review in Hypertension. Intensive blood pressure lowering vs. Standard blood pressure lowering was evaluated. Intensive blood pressure lowering is advisable only in specific subgroups of hypertensive patients where benefits outweigh risks, as current trial data are not easily applicable to the general population.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: